Research and Markets: Time and Cost Reduction in Clinical Trials - Outsourcing and IT to Optimize Patient Recruitment, Log

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/11c421/time_and_cost_redu) has announced the addition of the "Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management" report to their offering.

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management. The report provides in-depth analysis of various strategies adopted for reducing the time and cost involved in clinical trials. The report analyzes the key factors which should be considered in efficient clinical trial processes. It gives a robust idea about how the application of technology can lead to time and cost efficient clinical trials.

Clinical trials are one of the most important parts of the drug development process. The various aspects involved in clinical trials such as implementation of technology, efficient supply chain management, proper site selection, patient recruitment, database management and others are important.

The Clinical Research Process - Clinical Development is one of the most time consuming stages so time efficient methods need to be incorporated

Clinical research is critical to the success of biopharmaceutical companies. Within it, the clinical trial is the most time consuming stage of drug development. Therefore, biopharmaceutical companies are focusing on ways to improve their efficiency of the clinical research process in order to maximize gains. This requires considerable investment from biopharmaceutical companies for the conduction of quality clinical trials.

Time and Cost Reduction in Clinical Trials, Clinical Research Process, 2010 The above figure shows the step-by-step process for a drug to be developed along with the time-line to pass through all the phases of clinical research to reach the patient population. Clinical research is conducted in humans to verify if a new drug or therapy is safe and effective for treating a disease or condition. Clinical trials are conducted in different phases and on average it takes 12 to 14 years to discover and market one new drug. Pharmaceutical and biotechnology companies spend approximately $900m in bringing each new drug into the market.

Cost Saving Scenario in Electronic Data Capture (EDC) - Use of Electronic Method Leads to Reduction in Cost of Clinical Trial

If EDC is utilized in a multi center clinical trial study of 40 sites with 1,000 patients and 100 CRF's, then potentially around $1.12m in cash could be saved. This clearly signifies that the EDC system should be implemented in order to reduce the cost of clinical trial.

Key Topics Covered:

1 Tables of Contents

2 Time and Cost Reduction in Clinical Trials- Introduction

3 Time and Cost Reduction in Clinical Trials- Clinical Trial Process

4 Biomarkers and Surrogate End-points Help in Reducing Time and Cost of Clinical Trials

5 Site Selection and Management - Facilitates Cost and Time Efficient Clinical Trial

6 Effective and Efficient Supply Chain Management Reduces Time Lag

7 Information Technology Helps in Improving Clinical Trial Management

8 Implementation of Clinical Data Interchange Standards Consortium (CDISC) Standards Reduces Cost of Clinical Trials

9 Outsourcing- Contract Research Organizations (CROs) are Re-defining the Conduct of Clinical Trials

10 Profile of Key Companies Dealing in Clinical Trial Processes

Companies Mentioned:

  • Paragon Biomedical
  • Exodon
  • D. Anderson & Co
  • KIKA Medical
  • Omnicomm Systems
  • eResearch Technology
  • Prelude Dynamics
  • Clinipace
  • Phase Forward
  • Perceptive Informatics
  • DZS/ Clinplus
  • Quintiles
  • Covance
  • Pharmaceutical Product Development (PPD)
  • Charles River Laboratories
  • PAREXEL International

For more information visit http://www.researchandmarkets.com/research/11c421/time_and_cost_redu



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Clinical Trials

MEDIA:

Logo
 Logo

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.